2010-6246. Product Jurisdiction; Change of Address and Telephone Number; Technical Amendment  

  • Start Preamble

    Agency:

    Food and Drug Administration, HHS.

    Action:

    Final rule; technical amendment.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending its regulations to reflect a change in the address and telephone number for the Office of Combination Products (OCP). This action is editorial in nature and is intended to improve the accuracy of the agency's regulations.

    DATES:

    Effective Date: April 19, 2010.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    John Barlow Weiner, Office of Combination Products, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5130, Silver Spring, MD 20993-0002, 301-796-8930. To confirm that this change of address and telephone number has occurred, please see our Web site at www.fda.gov/​CombinationProducts/​default.htm.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    FDA is amending its regulations in 21 CFR part 3 to reflect a change in the address and telephone number for OCP. Publication of this document constitutes final action on this change under the Administrative Procedure Act (5 U.S.C. 553). Notice and public procedures are unnecessary because FDA is merely updating nonsubstantive content.

    Start List of Subjects

    List of Subjects in 21 CFR Part 3

    • Administrative practice and procedure
    • Biologics
    • Combination products
    • Drugs
    • Medical devices
    End List of Subjects Start Amendment Part

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 3 is amended as follows:

    End Amendment Part Start Part

    PART 3—PRODUCT JURISDICTION

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 3 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 321, 351, 353, 355, 360, 360c-360f, 360h-360j, 360gg-360ss, 360bbb-2, 371(a), 379e, 381, 394; 42 U.S.C. 216, 262, 264.

    End Authority
    [Amended]
    Start Amendment Part

    2. Section 3.6 is amended by removing “(HFG-3), Food and Drug Administration, 15800 Crabbs Branch Way, suite 200, Rockville, MD 20855, 301-427-1934”and by adding in its place “Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5129, Silver Spring, MD 20993-0002, 301-796-8930,”.

    End Amendment Part Start Signature

    Dated: March 17, 2010.

    Leslie Kux,

    Acting Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2010-6246 Filed 3-22-10; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
03/23/2010
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; technical amendment.
Document Number:
2010-6246
Pages:
13678-13678 (1 pages)
Docket Numbers:
Docket No. FDA-2010-N-0010
PDF File:
2010-6246.pdf
CFR: (1)
21 CFR 3.6